Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-0152-2027

Philips Lumify Diagnostic Ultrasound System Recall

Philips Lumify Diagnostic Ultrasound System

FDA recall Class I

Ongoing

FDA lists this Class I recall for Philips Lumify Diagnostic Ultrasound System. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-0152-2027
Recall classification
Class I
Enforcement status
Ongoing
Initiation date
Sep 24, 2026
FDA report date
Oct 28, 2026
Quantity in commerce
13,206
Distribution
See key details
FDA cause
Device Design

What is being recalled?

Philips Lumify Diagnostic Ultrasound System

The retrieved code information does not contain explicit model/GTIN pairs that this publication can reliably map.

Search FDA identifier text

Search a model, catalog, lot or UDI value exactly as printed in FDA’s product description or code information.

This search checks only the FDA product description and code information displayed on this page. It does not decode a UDI, normalize GTIN lengths or establish a relationship between separately listed codes.

FDA code information

UDI-DI/Software Version: Android: 00884838122116/1.X, 3.X, 4.X, 5.X. iOS: 00884838124141/2.X and 5.X

View the original FDA recall notice

Why was this product recalled?

Ultrasound system may: 1) Not recognize previous transducer registration, prevent scanning, require re-registration with Wi-Fi/cellular access, which may be unavailable outside of the hospital (ambulances/aircraft/field); 2) At connection between transducer USB cable to tablet/phone, there may be an unstable connection/may disconnect disrupting function. May cause diagnosis/treatment delay.

What actions did Philips Ultrasound, LLC take?

On 9/24/2026, correction notices were mailed to customers who were asked to do the following: Until software update is available and installed: " Do not use the affected systems outside of areas with readily accessible Wi-Fi/Cellular (e.g. prehospital transport (ambulance, helicopter) or use outside of a traditional healthcare setting (care in the field). " Always have backup ultrasound devices and/or modalities available for care as advised in the User Guide. " Circulate this notice to all users of the device so that they are aware of the product issue and associated hazard / harm. " Post this notice near the affected unit(s) for ease of reference. " Forward this notice to any area/facility that may have the device. Additionally: 1) Complete and return the response form via email to [email protected] 2) Firm is developing a software update to address the identified registration issue. Firm is also assessing the unstable cable connection issue to identify the appropriate solution. Firm will communicate once the software update is available and provide instructions on any actions required. Questions can be directed to the firm's local representatives or to the Customer Care Solutions Center (1-800-722-9377).

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology